¼¼°èÀÇ CADD(Computer-Aided Drug Discovery) ½ÃÀå
Computer-Aided Drug Discovery
»óǰÄÚµå : 1551560
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 375 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

CADD(Computer-Aided Drug Discovery) ¼¼°è ½ÃÀå, 2030³â±îÁö 71¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»ó

2023³â 36¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â CADD(Computer-Aided Drug Discovery) ¼¼°è ½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 9.9% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 71¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¸®°£µå ±â¹Ý ¼³°è´Â CAGR 10.7%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ÀÌ ³¡³¯ ¶§±îÁö 32¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±¸Á¶ ±â¹Ý ¼³°è ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 9.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀå 9¾ï 9,390¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 13.7%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ CADD(Computer-Aided Drug Discovery) ½ÃÀåÀº 2023³â 9¾ï 9,390¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 15¾ï ´Þ·¯ ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È 13.7%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 7.3%¿Í 8.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¿¬Æò±Õ 7.9%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è CADD(Computer-Aided Drug Discovery) ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

CADD(Computer-Aided Drug Discovery)ÀÇ ±¸Á¶¿Í Çٽɱâ¼úÀº?

CADD(Computer-Aided Drug Discovery)(CADD)Àº °è»êÀû ±â¹ýÀ» Ȱ¿ëÇÏ¿© ±âÁ¸¿¡´Â ½Ã°£°ú ºñ¿ëÀÌ ¸¹ÀÌ ¼Ò¿äµÇ´Â ½Å¾à°³¹ß °úÁ¤À» °¡¼ÓÈ­Çϰí Á¤±³È­ÇÏ´Â ÃÖ÷´Ü Á¢±Ù¹ýÀÔ´Ï´Ù. ´Ü¹éÁú, È¿¼Ò µî »ý¹°ÇÐÀû Ç¥Àû°úÀÇ »óÈ£ÀÛ¿ëÀ» ¸ðµ¨¸µÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ °úÁ¤Àº Ç¥ÀûÀÇ ½Äº°¿¡¼­ ½ÃÀÛÇÏ¿© ¹æ´ëÇÑ È­ÇÕ¹° ¶óÀ̺귯¸®¸¦ ½ºÅ©¸®´×Çϰí, Ç¥Àû°ú È¿°úÀûÀ¸·Î °áÇÕÇÏ°í ±× È°¼ºÀ» Á¶ÀýÇÒ ¼ö ÀÖ´Â °¡´É¼ºÀ» ºÐ¼®ÇÏ´Â °ÍÀ¸·Î ½ÃÀ۵˴ϴÙ. ºÐÀÚ µµÅ·, ºÐÀÚ µ¿·ÂÇÐ ½Ã¹Ä·¹À̼Ç, Á¤·®Àû ±¸Á¶-Ȱ¼º »ó°ü°ü°è(QSAR) ¸ðµ¨¸µ°ú °°Àº ±â¼úÀº ÀÌ °úÁ¤¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ºÐÀÚ µµÅ·Àº ¾à¹° ºÐÀÚ°¡ Ç¥Àû ºÎÀ§¿¡ ¾î¶»°Ô °áÇÕÇÏ´ÂÁö¸¦ ¿¹ÃøÇϰí, ºÐÀÚ µ¿·ÂÇÐ ½Ã¹Ä·¹À̼ÇÀº ¾à¹°°ú Ç¥ÀûÀÇ º¹ÇÕüÀÇ ¾ÈÁ¤¼º°ú ½Ã°£ °æ°ú¿¡ µû¸¥ °Åµ¿¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇϸç, QSAR ¸ðµ¨¸µÀº È­ÇÐ ±¸Á¶¸¦ ±â¹ÝÀ¸·Î È­ÇÕ¹°ÀÇ »ý¹°ÇÐÀû Ȱ¼ºÀ» ¿¹ÃøÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ °è»ê µµ±¸´Â ½Å¾à °³¹ßÀÇ Ãʱ⠴ܰ踦 È¿À²È­ÇÒ »Ó¸¸ ¾Æ´Ï¶ó ¾àµ¿ÇÐ ¹× µ¶¼º ÇÁ·ÎÆÄÀÏÀ» ¿¹ÃøÇÏ¿© ¸®µå È­ÇÕ¹°ÀÇ ÃÖÀûÈ­¸¦ °¡´ÉÇÏ°Ô Çϰí, ±Ã±ØÀûÀ¸·Î ´õ È¿°úÀûÀÌ°í ¾ÈÀüÇÑ ÀǾàǰÀ» »ý»êÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

CADD(Computer-Aided Drug Discovery)ÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖ´Â »ç¶÷Àº ´©±¸À̸ç, ¾î¶»°Ô Á¦¾à¿¬±¸¸¦ Çõ½ÅÇϰí Àִ°¡?

CADD(Computer-Aided Drug Discovery)ÀÇ ÇýÅÃÀº Á¦¾à¾÷°è, Çаè, ¿¬±¸±â°ü, ±×¸®°í ±Ã±ØÀûÀ¸·Î »õ·Î¿î È¿°úÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ ½Å¼ÓÇÑ Á¢±ÙÀ» ÅëÇØ ÇýÅÃÀ» ¹Þ´Â ȯÀڵ鿡°Ô±îÁö È®´ëµÉ ¼ö ÀÖ½À´Ï´Ù. Á¦¾àȸ»ç´Â ½Å¾à Ãâ½Ã¿¡ ¸·´ëÇÑ Àڱݰú ½Ã°£Àû ¾Ð¹ÚÀ» ¹Þ°í ÀÖÁö¸¸, CADD°¡ Á¦°øÇÏ´Â È¿À²¼ºÀ» ÅëÇØ Å« ÀÌÀÍÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. CADD´Â ´ë±Ô¸ð ½ÇÇè½Ç ½ÇÇèÀÇ Çʿ伺À» ÁÙÀÌ°í ¼ö¹é¸¸ °³ÀÇ È­ÇÕ¹°À» ½Å¼ÓÇÏ°Ô ½ºÅ©¸®´×ÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á À¯¸ÁÇÑ ½Å¾à Èĺ¸¹°ÁúÀÇ ¹ß±¼À» °¡¼ÓÈ­Çϰí, ½Å¾à°³¹ß°ú °ü·ÃµÈ ½Ã°£°ú ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÇÐ°è ¿¬±¸ÀÚµéÀº CADD¸¦ Ȱ¿ëÇÏ¿© »õ·Î¿î Ä¡·á Ç¥Àû°ú ÀÛ¿ë±âÀüÀ» Ž»öÇϰí, ±âÁ¸ ¹æ¹ýÀ¸·Î´Â Ä¡·áÇϱ⠾î·Á¿ü´ø Áúº´¿¡ ´ëÇÑ Çõ½ÅÀûÀÎ ¾à¹°À» ¹ß°ßÇϰí ÀÖ½À´Ï´Ù. ȯÀڵ鿡°Ô CADDÀÇ È¿°ú´Â ºÎÀÛ¿ëÀÌ Àû°í º¸´Ù Ç¥ÀûÈ­µÈ Ä¡·á¹ýÀÇ ÇüÅ·Π³ªÅ¸³³´Ï´Ù. °è»ê ¸ðµ¨¸µÀÇ Á¤È®¼ºÀº °Ç°­ÇÑ ¼¼Æ÷¿ÍÀÇ »óÈ£ÀÛ¿ëÀ» ÃÖ¼ÒÈ­Çϸ鼭 Áúº´À» À¯¹ßÇÏ´Â ºÐÀÚ¿Í Æ¯ÀÌÀûÀ¸·Î »óÈ£ÀÛ¿ëÇϵµ·Ï Á¶Á¤µÈ ¾à¹°À» ¼³°èÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù. ±× °á°ú, CADD(Computer-Aided Drug Discovery)Àº Á¦¾à »ê¾÷À» º¯È­½Ãų »Ó¸¸ ¾Æ´Ï¶ó, º¸´Ù °³ÀÎÈ­µÇ°í È¿°úÀûÀÎ ÇコÄɾîÀÇ ±æÀ» ¿­¾î°¡°í ÀÖ½À´Ï´Ù.

CADD(Computer-Aided Drug Discovery)ÀÇ Ãֽбâ¼ú Çõ½Å°ú µ¿ÇâÀº?

CADD(Computer-Aided Drug Discovery) ºÐ¾ß´Â ºü¸£°Ô ÁøÈ­Çϰí ÀÖÀ¸¸ç, ¸î °¡Áö »õ·Î¿î Æ®·»µå¿Í Çõ½ÅÀÌ Á¦¾à ¿¬±¸ÀÇ ¹Ì·¡¸¦ Çü¼ºÇϰí ÀÖ½À´Ï´Ù. °¡Àå Áß¿äÇÑ ¹ßÀü Áß Çϳª´Â ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×(ML)À» CADD ÇÁ·Î¼¼½º¿¡ ÅëÇÕÇÏ´Â °ÍÀ¸·Î, AI ±â¹Ý ¾Ë°í¸®ÁòÀº ¹æ´ëÇÑ µ¥ÀÌÅÍ ¼¼Æ®¸¦ ºÐ¼®Çϰí, ÆÐÅÏÀ» ½Äº°Çϰí, Àü·Ê ¾ø´Â Á¤È®µµ·Î ½Å¾à Èĺ¸¹°ÁúÀÇ È°¼ºÀ» ¿¹ÃøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ½Å±Ô È­ÇÕ¹° »ý¼º, ±âÁ¸ È­ÇÕ¹° ÃÖÀûÈ­, ÀÓ»ó °á°ú ¿¹Ãø±îÁö ÀÚÀ²ÀûÀ¸·Î ¼öÇàÇÏ´Â AI ±â¹Ý ½Å¾à°³¹ß Ç÷§ÆûÀÌ µîÀåÇϰí ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ Æ®·»µå´Â Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ°ú ºòµ¥ÀÌÅÍ ºÐ¼®ÀÇ È°¿ë È®´ëÀÔ´Ï´Ù. Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ°ú ºòµ¥ÀÌÅÍ ºÐ¼®À» ÅëÇØ ¿¬±¸ÀÚµéÀº ºÐ»ê ÄÄÇ»ÆÃÀÇ ÈûÀ» Ȱ¿ëÇÏ¿© º¹ÀâÇÑ ½Ã¹Ä·¹À̼ǰú ´ë±Ô¸ð µ¥ÀÌÅÍ ¼¼Æ®¸¦ º¸´Ù È¿À²ÀûÀ¸·Î ºÐ¼®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾çÀÚÄÄÇ»ÆÃÀÇ µîÀåÀº ¾ÆÁ÷ Ãʱ⠴ܰèÀÌÁö¸¸, ¿øÀÚ ¼öÁØ¿¡¼­ ºÐÀÚ °£ »óÈ£ÀÛ¿ëÀ» ½Ã¹Ä·¹À̼ÇÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á CADD¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ¾à¹°ÀÇ È¿´É°ú ¾ÈÀü¼ºÀ» º¸´Ù Á¤È®ÇÏ°Ô ¿¹ÃøÇÒ ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À¯ÀüüÇÐ, ´Ü¹éÁúüÇÐ, ´ë»çüÇÐ µî ¸ÖƼ¿À¹Í½º µ¥ÀÌÅÍÀÇ È°¿ëÀº CADD¿¡¼­ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖÀ¸¸ç, Áúº´ ¸ÞÄ¿´ÏÁò¿¡ ´ëÇÑ º¸´Ù Á¾ÇÕÀûÀÎ ÀÌÇØ¿Í ½Å¾à Ÿ°ÙÀ» ½Äº°ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ½Å¾à °³¹ßÀÇ °¡´É¼ºÀ» ³ÐÈ÷°í, º¸´Ù ½Å¼ÓÇÏ°í ºñ¿ë È¿À²ÀûÀ̸ç Á¤È®ÇÑ Ä¡·á¹ýÀ» °³¹ßÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù.

CADD(Computer-Aided Drug Discovery) ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

CADD(Computer-Aided Drug Discovery) ½ÃÀåÀÇ ¼ºÀåÀº Á¦¾à ¹× »ý¸í°øÇÐ »ê¾÷ÀÇ Áö¼ÓÀûÀÎ º¯È­¸¦ ¹Ý¿µÇÏ´Â ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â Áúº´ »ý¹°ÇÐÀÇ º¹À⼺À¸·Î ÀÎÇØ ½Å¾à°³¹ß¿¡ ´õ Á¤±³ÇÑ µµ±¸°¡ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù´Â Á¡ÀÔ´Ï´Ù. ¾Ï, ½Å°æÁúȯ, Èñ±Í À¯ÀüÁúȯ°ú °°Àº Áúº´¿¡ ´ëÇÑ ÀÌÇØ°¡ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ·¯ÇÑ º¹ÀâÇÑ Áúº´¿¡ È¿°úÀûÀ¸·Î ´ëÀÀÇÒ ¼ö Àִ ǥÀûÄ¡·áÁ¦ÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ AI, ¸Ó½Å·¯´×, ¾çÀÚ ÄÄÇ»ÆÃ°ú °°Àº ±â¼ú ¹ßÀüÀº CADD¸¦ ´õ¿í °­·ÂÇÏ°í ½±°Ô »ç¿ëÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á ¾÷°è Àü¹Ý¿¡¼­ CADDÀÇ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖÀ¸¸ç, CADD´Â ½Å¾à °³¹ß ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÏ°í ±×¿¡ µû¸¥ ÀçÁ¤Àû À§ÇèÀ» ¿ÏÈ­ÇÏ´Â ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á ÀǾàǰ °³¹ß ºñ¿ëÀÇ »ó½Â°ú »õ·Î¿î Ä¡·áÁ¦ ½ÃÀå Ãâ½Ã ½Ã°£À» ´ÜÃàÇØ¾ß ÇÑ´Ù´Â ¾Ð¹Úµµ Å« ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ °³°³ÀÎÀÇ À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏ¿¡ µû¶ó ¸ÂÃãÇü Ä¡·á¹ýÀ» °³¹ßÇØ¾ß ÇÏ´Â ¸ÂÃãÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ƯÀ̼º°ú È¿´ÉÀÌ ³ôÀº ÀǾàǰÀ» ¼³°èÇÒ ¼ö ÀÖ´Â CADD ±â¼ú¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¦¾à»ç, Çаè, ±â¼ú Á¦°ø¾÷ü °£ÀÇ Çù·Â °­È­´Â Çõ½ÅÀ» ÃËÁøÇϰí CADDÀÇ ¿ª·®À» È®´ëÇÏ´Â µ¥¿¡µµ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© CADD(Computer-Aided Drug Discovery) ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ°í ¹Ì·¡ ÀÇ·á ¹ßÀüÀÇ Áß¿äÇÑ ¿øµ¿·ÂÀ¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÃÑ 36°Ç)

  • Bayer AG
  • Charles River Laboratories International, Inc.
  • ChemDiv, Inc.
  • Pharmaron Beijing Co.
  • BOC Sciences
  • Chemical Computing Group ULC
  • Curia Global, Inc.
  • Bioduro-Sundia
  • Aaranya Biosciences Pvt.
  • Aris Pharmaceuticals, Inc.

    ¸ñÂ÷

    Á¦1Àå Á¶»ç ¹æ¹ý

    Á¦2Àå ÁÖ¿ä ¿ä¾à

    • ½ÃÀå °³¿ä
    • ÁÖ¿ä ±â¾÷
    • ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
    • ¼¼°è ½ÃÀå Àü¸Á

    Á¦3Àå ½ÃÀå ºÐ¼®

    • ¹Ì±¹
    • ij³ª´Ù
    • ÀϺ»
    • Áß±¹
    • À¯·´
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ¿µ±¹
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • È£ÁÖ
    • Àεµ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿
    • À̶õ
    • À̽º¶ó¿¤
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ±âŸ Áßµ¿
    • ¾ÆÇÁ¸®Ä«

    Á¦4Àå °æÀï

    LSH
  • ¿µ¹® ¸ñÂ÷

    ¿µ¹®¸ñÂ÷

    Global Computer-Aided Drug Discovery Market to Reach US$7.1 Billion by 2030

    The global market for Computer-Aided Drug Discovery estimated at US$3.6 Billion in the year 2023, is expected to reach US$7.1 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2023-2030. Ligand-based Design, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$3.2 Billion by the end of the analysis period. Growth in the Structure-based Design segment is estimated at 9.5% CAGR over the analysis period.

    The U.S. Market is Estimated at US$993.9 Million While China is Forecast to Grow at 13.7% CAGR

    The Computer-Aided Drug Discovery market in the U.S. is estimated at US$993.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 13.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 8.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.

    Global Computer-Aided Drug Discovery Market - Key Trends and Drivers Summarized

    How Does Computer-Aided Drug Discovery Work and What Are Its Core Technologies?

    Computer-aided drug discovery (CADD) is a cutting-edge approach that leverages computational methods to accelerate and refine the drug discovery process, traditionally a time-consuming and costly endeavor. At its core, CADD involves the use of sophisticated algorithms and simulations to model the interactions between potential drug candidates and biological targets, such as proteins or enzymes. The process begins with the identification of a target, followed by the screening of vast libraries of chemical compounds, which are analyzed for their potential to bind effectively with the target and modulate its activity. Technologies such as molecular docking, molecular dynamics simulations, and quantitative structure-activity relationship (QSAR) modeling play pivotal roles in this process. Molecular docking, for instance, predicts how a drug molecule will fit into a target site, while molecular dynamics simulations provide insights into the stability and behavior of the drug-target complex over time. QSAR modeling helps in predicting the biological activity of compounds based on their chemical structure. These computational tools not only streamline the early stages of drug discovery but also allow for the optimization of lead compounds by predicting their pharmacokinetic and toxicity profiles, ultimately leading to more effective and safer drugs.

    Who Benefits from Computer-Aided Drug Discovery and How Is It Transforming Pharmaceutical Research?

    The benefits of computer-aided drug discovery extend across the pharmaceutical industry, academic research institutions, and ultimately, patients who stand to gain from faster access to new and effective treatments. Pharmaceutical companies, faced with the immense financial and time pressures of bringing new drugs to market, benefit significantly from the efficiency gains offered by CADD. By reducing the need for extensive laboratory experimentation and enabling the rapid screening of millions of compounds, CADD accelerates the identification of promising drug candidates, reducing both the time and cost associated with drug development. Academic researchers also leverage CADD to explore novel therapeutic targets and mechanisms of action, often leading to the discovery of innovative drugs for conditions that have been challenging to treat with conventional methods. For patients, the impact of CADD is seen in the form of more targeted therapies with fewer side effects, as the precision of computational modeling allows for the design of drugs that are tailored to interact specifically with disease-causing molecules while minimizing interactions with healthy cells. As a result, computer-aided drug discovery is not only transforming the pharmaceutical landscape but also paving the way for more personalized and effective healthcare.

    What Are the Latest Innovations and Trends in Computer-Aided Drug Discovery?

    The field of computer-aided drug discovery is rapidly evolving, with several emerging trends and innovations shaping the future of pharmaceutical research. One of the most significant developments is the integration of artificial intelligence (AI) and machine learning (ML) into the CADD process. AI-driven algorithms are capable of analyzing vast datasets, identifying patterns, and predicting the activity of drug candidates with unprecedented accuracy. This has led to the emergence of AI-based drug discovery platforms that can autonomously generate novel compounds, optimize existing ones, and even predict clinical outcomes. Another trend is the increasing use of cloud computing and big data analytics, which allow researchers to harness the power of distributed computing to perform complex simulations and analyze large datasets more efficiently. The rise of quantum computing, though still in its early stages, holds the potential to revolutionize CADD by enabling the simulation of molecular interactions at an atomic level, leading to more accurate predictions of drug efficacy and safety. Additionally, the use of multi-omics data, including genomics, proteomics, and metabolomics, is becoming increasingly important in CADD, enabling a more comprehensive understanding of disease mechanisms and the identification of new drug targets. These innovations are pushing the boundaries of what is possible in drug discovery, leading to faster, more cost-effective, and more precise therapeutic development.

    What Is Driving the Growth of the Computer-Aided Drug Discovery Market?

    The growth in the computer-aided drug discovery market is driven by several factors that reflect the ongoing transformation of the pharmaceutical and biotechnology industries. One of the primary drivers is the increasing complexity of disease biology, which demands more sophisticated tools for drug discovery. As diseases like cancer, neurological disorders, and rare genetic conditions become better understood, there is a growing need for targeted therapies that can address these complex conditions effectively. Technological advancements, particularly in AI, machine learning, and quantum computing, are making CADD more powerful and accessible, further driving its adoption across the industry. The rising cost of drug development and the pressure to reduce time-to-market for new therapies are also significant factors, as CADD offers a solution that can streamline the drug discovery process and reduce the financial risks associated with it. Additionally, the growing focus on personalized medicine, which requires the development of therapies tailored to individual patients based on their genetic profiles, is fueling demand for CADD technologies that can design drugs with high specificity and efficacy. The increasing collaboration between pharmaceutical companies, academic institutions, and technology providers is also fostering innovation and expanding the capabilities of CADD. Together, these factors are propelling the growth of the computer-aided drug discovery market, positioning it as a key driver of future advancements in medicine.

    Select Competitors (Total 36 Featured) -

    TABLE OF CONTENTS

    I. METHODOLOGY

    II. EXECUTIVE SUMMARY

    III. MARKET ANALYSIS

    IV. COMPETITION

    (ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
    ¨Ï Copyright Global Information, Inc. All rights reserved.
    PC¹öÀü º¸±â